Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples